Navigation Links
AMDL Inc. Announces Second Quarter 2008 Results; Company Posts $5.8 Million in Sales With a Revenue Increase of 140%
Date:8/15/2008

injection fluids, tablets and other related products. It currently manufactures over 20 key generic, over-the-counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

Forward-looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

AMDL Contact:

Kristine Szarkowitz

Director-Investor Relations

kszarkowitz@amdl.com

(M) (206) 310-5323

(O) (206) 201-3286


'/>"/>
SOURCE AMDL
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
2. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
3. Fufeng Announces 2008 Interim Results With Strong Sign of Recovery
4. Advanced Life Sciences Announces Second Quarter 2008 Financial Results
5. Ondine Biopharma Announces Second Quarter 2008 Financial Results
6. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
7. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
8. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
9. Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
10. POET Announces That Cellulosic Ethanol Pilot Facility Will Be Operational This Year
11. China Medicine Announces Strong Second Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...vember24/PRNewswire-FirstCall/--deCODE,genetics,In...ts,"firstday"motionsbytheU.S.BankruptcyCourtforthe...stweekfiledavoluntarypetitionfor,reliefunderChapte...cyCourt. , TheordersissuedbytheBankruptcyCour...ingtheChapter11proceedings.Inparticular,the,compan...
(Date:11/24/2009)...swire/--BlueMarbleEnergyCorp.announcedtodaythatthe...)wererecentlyawarded$2millionbyWashingtonState,sCo.../publicpartnershiptoconstructthestate,sfirstspecia... "Thisinvestmentwillsignificantlyspeedthedevelopme...County,"saidBlueMarbleEnergyCEOKellyOgilvie."Weare...
(Date:11/24/2009)...Newswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHP...day,announcedthatithassubmittedaMAAtotheEuropeanMe...ymereplacementtherapyindevelopment,forthetreatment...icationforvelaglucerasealfathathasbeensubmitted,wi..., Basedonaglobalsupplyshortageofthecurrentlya...
(Date:11/24/2009)...ogram Connects Customers with Partners Validated t...enotek Products , Ottawa,...leading provider of products for biological sample...announced its new global partner program. The prog...k,s partner community and is designed to help part...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
... least 45 girls in grades six through nine are exp...e held June 26 to 28 at Madison Area Technical Co...gy employers to encourage young women to consider ...ture hands-on technical activities that introduce ...ing, electronics and electron microscopy, and info...
...e Douglas Stewart Co. has entered into a distrib...on resellers the products of Honestech, Inc. , an...net Protocol (IP) communication and entertainment ...disclosed. , ,Douglas Stewart sells computer produ...a market of 4,500 academic resellers in the United...
...is is part II of a two-part column on the Food and...cused on the recent controversy over Avandia, Glax...efficacy over safety seems to be so deeply integra...e that this has not always been the case. For much...,s primary mandate was to protect the public,s sa...
Other Biology Technology:Reforming FDA: Focus on safety, let market judge efficacy 2Reforming FDA: Focus on safety, let market judge efficacy 3Reforming FDA: Focus on safety, let market judge efficacy 4Reforming FDA: Focus on safety, let market judge efficacy 5Reforming FDA: Focus on safety, let market judge efficacy 6
(Date:11/23/2009)...ON, WI, November 16, 2009 -- A USDOE and USDA stud..., idle cropland, and cropland pasture could be con...nnial grasses, such as switchgrass, from which bio...tock. Economically viable production of a perennia...ies of biomass are removed annually is expected to...
(Date:11/23/2009)...HAM, N.H. University of New Hampshire microbiolog...98,115 to advance understanding of the actinorhiza...o enrich nutrient-poor and contaminated soils. ,...A) awarded Tisa, a professor of molecular, cellula... symbiotic relationship between the bacteria Frank...
(Date:11/23/2009)...versity of Southern California biomedical engineer...lop a new tool to help clinicians distinguish card...hronic problems manageable with drugs and lifestyl... inserted into the arteries feeding the heart, off...) of these blood vessels, often revealing deposits...
Breaking Biology News(10 mins):Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Odd Behaviors on Ambien Linked to Brain Circuitry 50681 1Odd Behaviors on Ambien Linked to Brain Circuitry 50681 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 1 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 2 28RED 29ZONES Launch at First U2 360 Degrees Concert in Barcelona 50678 3Prostate cancer patients disease free after 5 years likely to be disease free after 10 years 50676 1
...ate University makes an animal heart pump much lik...animal,s body, allowing researchers to expedite th...t surgery. The machine saves researchers time and ...chnologies in a realistic surgical environment, wi...clinical trials. , , Currently, most medical devi...
...predators detect common forms of prey more easily....MC Ecology found that birds will target salamande...ir behavior in response to alterations in the rati...ick, from the University of Tennessee, worked with...of the prevalence of a dorsal stripe among a group...
...l Oceanic and Atmospheric Administration (NOAA) ha...new cooperative institute which will be headquarte...) at Florida Atlantic University in Fort Pierce, F...Carolina Wilmington (UNCW). This is the single lar...U since their inception. The Cooperative Institute...
Other Biology News:'Beating' heart machine expedites research and development of new surgical tools, techniques 2NOAA awards $22.5 million to Harbor Branch/FAU and UNCW for new cooperative institute 2NOAA awards $22.5 million to Harbor Branch/FAU and UNCW for new cooperative institute 3
Rabbit Anti-MSY2 / YBOX2 Polyclonal Antibody, Unconjugated from Abcam
Anti-SAPK / JNK Antibody, Unconjugated from Cell Signaling Technology
L-Selenomethionine from Calbiochem
PAP PEN from Invitrogen
Biology Products: